Ayala Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
10.08.2023 - Successful End-of-Phase 2 meeting with FDA regarding AL102 for the treatment of desmoid tumors Enrollment in the Phase 3 segment of RINGSIDE trial evaluating AL102 continuing globally as planned Definitive merger agreement with Biosight, expected .
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., May 23, 2023 Ayala Pharmaceuticals, Inc. , a clinical-stage oncology company, today announced first-quarter 2023 financial results and provided a. | May 23, 2023